# Aspira Pathlab & Diagnostics Ltd (ASPIRA)
> Exchange: NSE | Sector: Healthcare | ISIN: 

## Price
Current Price: ₹90.99
Day Change: +10%
52W High: ₹90.99
52W Low: ₹49
Market Cap: ₹94 Cr

## Valuation
P/E: 65.93
P/B: 6.5
EPS: ₹1.38
Book Value: ₹13.99
Dividend Yield: 0%

## Returns
1Y Return: 47.35%

## Profitability
ROE: 0%
ROCE: 0%
Debt/Equity: 0
Revenue Growth: 0%
Profit Growth: 0%
EBITDA Margin: 0%
Operating Margin: 0%

## About
Aspira Pathlab & Diagnostics Ltd is a Diagnostics & Research company listed on BSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Healthcare
Industry: Diagnostics & Research
Sub Industry: Unknown

## Business Model
Overview: Aspira Pathlab & Diagnostics Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Diagnostics & Research. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Healthcare.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
- Announcement: Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
- BSE Filing: Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2

## Data Freshness
Quote Updated: 2026-05-17T00:12:17.308Z
Price History Updated: 2026-05-19T01:02:30.413Z
Latest Price History Date: 2026-05-15
Technicals Updated: 2026-05-19T01:02:30.413Z
Quant Updated: 2026-05-19T01:02:30.413Z
Sentiment Updated: 2026-05-19T01:02:30.413Z
Financials Status: current
Financials Updated: 2026-05-18T13:30:00.909Z
Financials Last Attempt: 2026-05-18T13:30:00.909Z
Financials Provider Tried: database
Latest P&L Period: FY 2025
Latest Balance Sheet Period: FY 2025
Latest Cash Flow Period: FY 2025

## P&L (Mar 2025)
Revenue: ₹13.2 Cr
Operating Profit: ₹-1.18 Cr (OPM -8.94%)
Net Profit: ₹-2.67 Cr
Tax: ₹-2.67 Cr

## Annual P&L History
Mar 2025: Rev ₹13.2Cr | PAT ₹-2.67Cr | OPM -8.94%
TTM: Rev ₹22Cr | PAT ₹2.02Cr | OPM 15.95%

## Balance Sheet (Mar 2025)
Total Assets: ₹14.71 Cr
Total Liabilities: ₹14.71 Cr
Borrowings: ₹7.71 Cr
Cash: ₹undefined Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

---
Source: rupiya.io/stocks/aspira
Disclaimer: For research and education only. Not investment advice.